JAMES HARRIS: Open Payments
NPI 1710366570 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,040 in 61 payments from 15 companies in 2025. Trend: 2023 $1,098 · 2024 $954 · 2025 $3,040
Food & beverage: $1,598Travel & lodging: $1,442
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 26 | $2,025 |
| Stryker Corporation | 9 | $148 |
| Neurocrine BioSciences, Inc. | 1 | $125 |
| Ardelyx, Inc. | 1 | $125 |
| Melinta Therapeutics, LLC | 1 | $125 |
| Sage Therapeutics, LLC | 1 | $120 |
| Novartis Pharmaceuticals Corporation | 7 | $113 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $76 |
| Alnylam Pharmaceuticals Inc. | 4 | $61 |
| AtriCure, Inc. | 1 | $33 |
Products named: LINQ II, Rezzayo, IBSRELA, ARTIX MT, LEQVIO, AZURE XT DR MRI SURESCAN, Kerendia, COBALT DR MRI SURESCAN.
Industry payments across LA — which companies pay providers there.
